A Multiple Dose Study Of PF-06678552 In Healthy Subjects

PF-06678552 or placebo will be administered as an extemporaneously prepared solution every 12 hours for 14 days.

PF-06678552 or placebo will be administered as an extemporaneously prepared solution every 12 hours for 14 days.

PF-06678552 or placebo will be administered as an extemporaneously prepared solution every 12 hours for 14 days.

PF-06678552 or placebo will be administered as an extemporaneously prepared solution every 12 hours for 14 days.

PF-06678552 or placebo will be administered as an extemporaneously prepared solution every 12 hours for 14 days.

PF-06678552 or placebo will be administered as an extemporaneously prepared solution every 12 hours for 14 days.

PF-06678552 or placebo will be administered as an extemporaneously prepared solution every 12 hours for 14 days.

PF-06678552 or placebo will be administered as an extemporaneously prepared solution every 12 hours for 14 days.

PF-06678552 or placebo will be administered as an extemporaneously prepared solution either once daily (QD), every 12 hours (Q12H), or every 8 hours (Q8H) for 14 days.

PF-06678552 or placebo will be administered as an extemporaneously prepared solution either once daily (QD), every 12 hours (Q12H), or every 8 hours (Q8H) for 14 days.

PF-06678552 or placebo will be administered as an extemporaneously prepared solution either once daily (QD), every 12 hours (Q12H), or every 8 hours (Q8H) for 14 days.

PF-06678552 or placebo will be administered as an extemporaneously prepared solution either once daily (QD), every 12 hours (Q12H), or every 8 hours (Q8H) for 14 days.